Osteosarcoma of the pelvis: experience of the Cooperative Osteosarcoma Study Group.

PURPOSE To define patients and tumor characteristics as well as therapy results, patients with pelvic osteosarcoma who were registered in the Cooperative Osteosarcoma Study Group (COSS) were analyzed. PATIENTS AND METHODS Sixty-seven patients with a high-grade pelvic osteosarcoma were eligible for this analysis. Fifteen patients had primary metastases. All patients received chemotherapy according to COSS protocols. Thirty-eight patients underwent limb-sparing surgery, 12 patients underwent hemipelvectomy, and 17 patients did not undergo definitive surgery. Eleven patients received irradiation to the primary tumor site: four postoperatively and seven as the only form of local therapy. RESULTS Local failure occurred in 47 of all 67 patients (70%) and in 31 of 50 patients (62%) who underwent definitive surgery. Five-year overall survival (OS) and progression-free survival rates were 27% and 19%, respectively. Large tumor size (P =.0137), primary metastases (P =.0001), and no or intralesional surgery (P <.0001) were poor prognostic factors. In 30 patients with no or intralesional surgery, 11 patients with radiotherapy had better OS than 19 patients without radiotherapy (P =.0033). Among the variables, primary metastasis, large tumor, no or intralesional surgery, no radiotherapy, existence of primary metastasis (relative risk [RR] = 3.456; P =.0009), surgical margin (intralesional or no surgical excision; RR = 5.619; P <.0001), and no radiotherapy (RR = 4.196; P =.0059) were independent poor prognostic factors. CONCLUSION An operative approach with wide or marginal margins improves local control and OS. If the surgical margin is intralesional or excision is impossible, additional radiotherapy has a positive influence on prognosis.

[1]  G. Rosen,et al.  Neoadjuvant chemotherapy for osteogenic sarcoma: a five year follow-up (T-10) and preliminary report of new studies (T-12). , 1985, Progress in clinical and biological research.

[2]  G. Rosen,et al.  Primary osteogenic sarcoma: the rationale for preoperative chemotherapy and delayed surgery. , 1979, Cancer.

[3]  M. Campanacci,et al.  Pelvic resections: the Rizzoli Institute experience. , 1991, The Orthopedic clinics of North America.

[4]  F. Sim,et al.  [Resection of pelvic sarcomas. Reconstruction techniques without use of endoprostheses]. , 1993, Der Orthopade.

[5]  R Maas,et al.  Tumor size and prognosis in aggressively treated osteosarcoma. , 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[6]  D. Eastwood,et al.  Hindquarter amputation for tumours of the musculoskeletal system. , 1990, The Journal of bone and joint surgery. British volume.

[7]  H. Jürgens,et al.  Neoadjuvant chemotherapy of osteosarcoma: results of a randomized cooperative trial (COSS-82) with salvage chemotherapy based on histological tumor response. , 1988, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[8]  O. Schober,et al.  High-Activity Samarium-153-EDTMP Therapy in Unresectable Osteosarcoma , 1999, Nuklearmedizin.

[9]  W. Winkelmann,et al.  Prognostic factors in high-grade osteosarcoma of the extremities or trunk: an analysis of 1,702 patients treated on neoadjuvant cooperative osteosarcoma study group protocols. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[10]  M. Simon,et al.  Oncologic outcomes of primary bone sarcomas of the pelvis. , 1994, Clinical orthopaedics and related research.

[11]  L. Wurtz,et al.  Delay in the diagnosis and treatment of primary bone sarcoma of the pelvis. , 1999, The Journal of bone and joint surgery. American volume.

[12]  L. Hartmann,et al.  High-dose samarium-153 ethylene diamine tetramethylene phosphonate: low toxicity of skeletal irradiation in patients with osteosarcoma and bone metastases. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[13]  U. Göbel,et al.  Neoadjuvante Therapie des lokalisierten Osteosarkoms der Extremitäten , 1999 .

[14]  A. Huvos,et al.  Osteosarcoma of the Pelvis: Oncologic Results of 40 Patients , 1998, Clinical orthopaedics and related research.

[15]  W. Ebell,et al.  Neoadjuvant chemotherapy for osteogenic sarcoma: results of a Cooperative German/Austrian study. , 1984, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[16]  H. Imhof,et al.  Preoperative staging of osteosarcoma: efficacy of MR imaging in detecting joint involvement. , 1994, AJR. American journal of roentgenology.

[17]  D. Campanacci,et al.  Limb sparing versus amputation in osteosarcoma. Correlation between local control, surgical margins and tumor necrosis: Istituto Rizzoli experience. , 1992, Annals of oncology : official journal of the European Society for Medical Oncology.

[18]  S. Bielack,et al.  Osteosarcoma of the trunk treated by multimodal therapy: experience of the Cooperative Osteosarcoma study group (COSS). , 1995, Medical and pediatric oncology.

[19]  G. Pignatti,et al.  Resection of malignant bone tumors of the pelvic girdle without extremity amputation. , 1988, Archives of surgery.

[20]  K. Unni,et al.  Dahlin's Bone Tumors: General Aspects and Data on 11,087 Cases , 1996 .

[21]  W. Taylor,et al.  Trends and variability in survival from osteosarcoma. , 1978, Mayo Clinic proceedings.

[22]  S. Leyvraz,et al.  Effect of intraarterial versus intravenous cisplatin in addition to systemic doxorubicin, high‐dose methotrexate, and ifosfamide on histologic tumor response in osteosarcoma (study COSS‐86) , 1990, Cancer.

[23]  G. Delling,et al.  [Determination of the degree of morphological regression following chemotherapy in malignant bone tumors]. , 1983, Der Pathologe.

[24]  A. Aboulafia,et al.  Surgical management of pelvic and extremity osteosarcoma , 1993, Cancer.

[25]  G. Rosen,et al.  Primary osteogenic sarcoma: Eight-year experience with adjuvant chemotherapy , 2004, Journal of Cancer Research and Clinical Oncology.

[26]  M. Marangolo,et al.  Treatment of pelvic osteosarcoma. , 1992, Annals of oncology : official journal of the European Society for Medical Oncology.

[27]  W. Enneking.  A system of staging musculoskeletal neoplasms. , 1986, Clinical orthopaedics and related research.

[28]  J. Krischer,et al.  Interval between symptom onset and diagnosis of pediatric solid tumors. , 1991, The Journal of pediatrics.

[29]  A. Skretting,et al.  Targeted radiotherapy of osteosarcoma using 153 Sm-EDTMP. A new promising approach. , 1996, Acta oncologica.

[30]  S. Ferrari,et al.  Osteogenic sarcoma of the extremity with detectable lung metastases at presentation , 1997, Cancer.

[31]  W. Enneking,et al.  Resection and reconstruction for primary neoplasms involving the innominate bone. , 1978, The Journal of bone and joint surgery. American volume.

[32]  W. Winkelmann,et al.  High complication rates with pelvic allografts. Experience of 22 sarcoma resections. , 1996, Acta orthopaedica Scandinavica.

[33]  A. Schiller,et al.  The management of chondrosarcoma of bone. , 1980, Clinical orthopaedics and related research.

[34]  H. Greenberg,et al.  Primary treatment of pelvic osteosarcoma: Report of five cases , 2010, Cancer.

[35]  M. Fahey,et al.  Osteosarcoma of the pelvis. A clinical and histopathological study of twenty-five patients. , 1992, The Journal of bone and joint surgery. American volume.

[36]  K. D. Devine,et al.  Osteosarcoma of the jaw , 1983, Cancer.

[37]  G. Krol,et al.  Combined treatment of osteosarcoma of the spine. , 1988, Neurosurgery.

[38]  R. Grimer,et al.  Osteosarcoma of the pelvis. , 1999, The Journal of bone and joint surgery. British volume.

[39]  W. Enneking,et al.  A System for the Surgical Staging of Musculoskeletal Sarcoma , 1980, Clinical orthopaedics and related research.

[40]  L. Hovelius,et al.  Report of Five Cases , 1977 .